Cargando…
Extinction of the Influenza B Yamagata Line during the COVID Pandemic—Implications for Vaccine Composition
Autores principales: | Vajo, Zoltan, Torzsa, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414795/ https://www.ncbi.nlm.nih.gov/pubmed/36016367 http://dx.doi.org/10.3390/v14081745 |
Ejemplares similares
-
Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?
por: Paget, John, et al.
Publicado: (2022) -
A Reduced Dose Whole Virion Aluminum Adjuvanted Seasonal Influenza Vaccine Is Immunogenic, Safe, and Well Tolerated in Pediatric Patients †
por: Vajo, Zoltan, et al.
Publicado: (2021) -
Developing Immunity Testing for SARS-CoV-2 and Other Novel Vaccines—Correlates of Immunogenicity Parameters with Protection
por: Vajo, Zoltan
Publicado: (2022) -
Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season
por: Korsun, N. S., et al.
Publicado: (2019) -
Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design
por: da Costa, Kelly A. S., et al.
Publicado: (2022)